Pronacera is a biotechnology company focused on the development of genetic diagnostic tools and treatments for pathologies across various medical fields, such as reproduction, fibromyalgia, and rare diseases or those with diagnostic gaps. Our objective is to assist in the optimization of healthcare systems by improving diagnostic timeframes and methodologies.
Among the multiple R&D lines currently under development, the reproductive genomics and endometrial functional molecular biology line is particularly prominent. Specifically, the company develops marker designs and performs genetic analysis of infertility focused on female endometrial tissue.
Our genomic research focuses on reproductive health and diagnostic challenges, committing ourselves to well-being and medical advancement.
Qualification, transparency, commitment to science, passion for health, advanced innovation, social responsibility, honesty, and success.
To ensure that genetics is always at the service of health and people’s well-being, elevating their quality of life to the highest level.
At Pronacera, we believe that scientific innovation can change lives. Our purpose is to offer accurate diagnostics and advanced treatments that transform medicine, bringing new hope to those facing complex health challenges. Every breakthrough in our research is designed to improve quality of life and anticipate the future of personalized medicine.
